- Home
- ZNTL vs FTRA Comparison
ZNTL vs FTRA Comparison
Compare ZNTL & FTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZNTL | FTRA |
|---|---|---|
| Founded | 2014 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.0M | 283.5M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | FTRA |
|---|---|---|
| Price | $2.41 | $9.88 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 36.7K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.21 | $9.85 |
| 52 Week High | $6.95 | $9.95 |
Technical Indicators
Market Signals| Indicator | ZNTL | FTRA |
|---|---|---|
| Relative Strength Index (RSI) | 32.31 | 51.82 |
| Support Level | $2.09 | $9.86 |
| Resistance Level | $2.76 | $9.90 |
| Average True Range (ATR) | 0.16 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 7.00 | 100.00 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About FTRA FutureCorp Space Acquisition 1 Class A Ordinary Shares
FutureCorp Space Acquisition 1 is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.